Pharmacists Work to Sustain Care in Health Care Deserts
Drug Topics
SEPTEMBER 29, 2023
When rural areas lose hospitals and primary care clinics, residents must turn to pharmacies to receive the care they need.
Fri.Sep 29, 2023
653 
3 recent FDA adcomm rejections — and why they matter
PharmaVoice
SEPTEMBER 29, 2023
Decisions that could spell doom for drugs in development and already on the shelves.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Independent Pharmacies Say They Can Help Patients Impacted by Chain Store Closures, NCPA Survey Finds
Drug Topics
SEPTEMBER 29, 2023
A new poll from the organization surveyed 10000 independent community pharmacy owners on current worries in the industry and how they are being impacted by the ongoing national drug shortage.
WHO recommends dropping component of many flu vaccines
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Leverage Small Business Saturday to Drive Sales, Build Partnerships
Drug Topics
SEPTEMBER 29, 2023
Small Business Saturday was created by American Express in 2010 and represents an important sales opportunity for independent community pharmacies across the United States.
Incidence of Type 2 Diabetes Increased Significantly Following COVID-19 Pandemic
Pharmacy Times
SEPTEMBER 29, 2023
Investigators also found that rates of type 1 diabetes have been on the rise since 2016.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study Finds Individuals Prefer PrEP Over Other HIV Prevention Methods
Pharmacy Times
SEPTEMBER 29, 2023
Individuals taking HIV prevention prefer the PrEP oral daily dose compared to new treatment methods.
Innovative Solutions in Medication Packaging Can Improve Adherence
Drug Topics
SEPTEMBER 29, 2023
Near-field communication (NFC)-enabled medication blister packaging can help patients improve their medication adherence.
Lead Investigator Provides Insight Into FDA Approval of Momelotinib for Myelofibrosis
Pharmacy Times
SEPTEMBER 29, 2023
Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.
Women spend 20% more per year on out-of-pocket health costs, says report
STAT
SEPTEMBER 29, 2023
Women of all ages pay a total of $15.4 billion more than men on annual out-of-pocket medical expenses, according to a new report from Deloitte. In 2021, that meant that women paid about 20% more than men — only 2% of which could be accounted for by maternity care. The fact that the way benefits are currently designed “puts a disproportionate cost on women, above and beyond maternity, was the thing that really surprised us,” said Kulleni Gebreyes, a physician who runs Deloitt
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Bridging the Gap: Industry-Academia Collaboration in Pharmacy
Pharmacy Times
SEPTEMBER 29, 2023
The most persuasive reason for industry-academia collaboration is the many opportunities it opens for pharmacy students who may not have considered all the ways they can use their PharmD to serve the cause of humankind.
STAT+: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’
STAT
SEPTEMBER 29, 2023
The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks. Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision.
Analysis Indicates Sleep Duration, Health Influenced by Environmental Changes
Pharmacy Times
SEPTEMBER 29, 2023
Environmental factors may change sleep patterns over time, which subsequently affects rapid eye movement sleep.
STAT+: Taysha Gene Therapies’ plan to tackle rare diseases is crumbling
STAT
SEPTEMBER 29, 2023
In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases. The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Researchers Reframe the Definition of Clinical Remission for Asthma
Pharmacy Times
SEPTEMBER 29, 2023
A workgroup of asthma treatment experts introduced 6 new criteria that those diagnosed with asthma must meet to be in remission.
The PharmaVoice 100: Trailblazers
PharmaVoice
SEPTEMBER 29, 2023
Leaders who are going where no biopharma executive has gone before and changing the industry along the way.
STAT+: Sales from controversial drug discount program rose to $54 billion last year
STAT
SEPTEMBER 29, 2023
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $53.7 billion in 2022, an 18% increase from the previous year, according to the U.S. Health Resources & Service Administration, which oversees the program. The latest data mark a steady rise in sales under the 340B Drug Discount Program, which requires drugmakers to offer discounts that are typically estimated to be 25% to 50% — but could be higher — of all outpatient drug
Topline Data Demonstrate Survival Improvement With Amivantamab-vmjw for NSCLC
Pharmacy Times
SEPTEMBER 29, 2023
The MARIPOSA study evaluated amivantamab-vmjw (Rybrevant; Janssen Pharmaceutical) in combination with lazertinib compared to osimertinib and compared to lazertinib monotherapy in the first-line treatment of EGFR-mutated non–small cell lung cancer.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Unitaid slams J&J over pricing and patents for a tuberculosis drug
STAT
SEPTEMBER 29, 2023
In a highly unusual move, Unitaid has publicly criticized Johnson & Johnson over its pricing and patenting policies for a key drug used to combat tuberculosis. The global health organization released a letter urging the company to drop so-called secondary patents for its medicine, known as bedaquiline, and to make negotiated prices for the drug available to all countries, regardless of existing arrangements for making purchases.
Medicare enrollment begins in 2 weeks. Here's what major payers are offering for 2024
Fierce Healthcare
SEPTEMBER 29, 2023
The industry is just two weeks away from the beginning of Medicare's annual enrollment period, a critical window for the hottest market in insurance. | The industry is just two weeks away from the beginning of Medicare's annual enrollment period, a critical window for the hottest market in insurance.
Opinion: AI-driven data analysis could exacerbate misaligned incentives in biomedical research
STAT
SEPTEMBER 29, 2023
This summer OpenAI released Code Interpreter , a plug-in for the popular ChatGPT tool that allows it to take in datasets, write and run Python code, and “ create charts, edit files, perform math, etc. “ It aims to be nothing short of the ideal statistical collaborator or research software engineer, providing the necessary skill and speed to overcome the limitations of one’s research program at a fraction of the price.
Eli Lilly moves to settle with whistleblower who flagged alleged manufacturing shortfalls
Fierce Pharma
SEPTEMBER 29, 2023
After a former human resources officer blew the whistle on alleged manufacturing shortfalls at Eli Lilly’s massive Branchburg, New Jersey, production plant, the parties have been engaged in settlem | After a former human resources officer blew the whistle on alleged manufacturing shortfalls at Eli Lilly’s massive Branchburg, New Jersey, production plant, the parties have been engaged in settlement talks.
Prescription for success: How creativity is the secret ingredient in pharma marketing
pharmaphorum
SEPTEMBER 29, 2023
Prescription for success: How creativity is the secret ingredient in pharma marketing Mike.
Insurers argue that they're not to blame for snags in COVID-19 vaccine rollout
Fierce Healthcare
SEPTEMBER 29, 2023
Major payers promised to iron out snags involved in the rollout of the ne | Insurers cite some obstacles not in their control that contributed to problems with the rollout of the new COVID-19 vaccine.
The future of cancer care: Fast-tracking sustainability, access, and innovation in the Middle East
pharmaphorum
SEPTEMBER 29, 2023
The future of cancer care: Fast-tracking sustainability, access, and innovation in the Middle East Mike.
STAT+: Generic makers fall short when providing access to low- and middle-income countries, analysis finds
STAT
SEPTEMBER 29, 2023
A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found. For instance, just one of 50 different treatments marketed by these companies — Teva Pharmaceuticals, Sun Pharmaceutical, Cipla, Hikma Pharmaceuticals, and Viatris — had a pricing strategy in place that considered a patient’s ability to pay.
Biogen shuts digital health unit and exits Apple alliance
pharmaphorum
SEPTEMBER 29, 2023
Biogen shuts digital health unit and exits Apple alliance Phil.
STAT+: Pharmalittle: Deadline looms for drugmakers to negotiate with Medicare; GOP senator probes 340B program at two hospitals
STAT
SEPTEMBER 29, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. Weather permitting, we expect to promenade with the official mascots, take a nap or three and, perhaps, hold another listening party with Mrs. Pharmalot. The rotation will likely include this , this , this , and this.
pH-D Feminine Health debuts Boric Acid Gel
Drug Store News
SEPTEMBER 29, 2023
The gel aims to help alleviate discomfort experienced during feminine health journeys, the company said.
MSD eyes March FDA decision on PAH drug sotatercept
pharmaphorum
SEPTEMBER 29, 2023
MSD eyes March FDA decision on PAH drug sotatercept Phil.
Karuna Therapeutics files for FDA approval for schizophrenia treatment
Pharmaceutical Technology
SEPTEMBER 29, 2023
Karuna Therapeutics has announced the submission of a NDA to the FDA for KarXT (xanomeline-trospium) for the treatment of schizophrenia.
Chemo-free regimen demonstrates efficacy in NSCLC
European Pharmaceutical Review
SEPTEMBER 29, 2023
Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III MARIPOSA study is the first to show a clinically meaningful benefit in a chemotherapy-free regimen compared to the small molecule treatment TAGRISSO ® ( osimertinib ). This is based on positive topline results for Rybrevant ® (amivantamab-vmjw) in combination with lazertinib, as first-line anti-cancer treatment in locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).
Let's personalize your content